For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Liver enzymes through a pragmatic lens: Interpreting alanine aminotransferase elevation
+Print Archive
Practice
Liver enzymes through a pragmatic lens: Interpreting alanine aminotransferase elevation
Wednesday 11 September 2019, 01:00 AM

Medication is a very common cause for abnormal liver enzymes
FROM THE LAB
This article, the second in a three-part series on liver enzymes, introduces alanine aminotransferase and describes how to go about investigating elevations in this biomarker for liver health
Reports of the degrees of elevation that define mild versus moderate or severe elevation of liver enzymes vary in the literature...
Key points
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.